Beta Bionics faces a class action lawsuit for allegedly making false statements about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The lawsuit claims the company misled investors by downplaying FDA concerns after a facility inspection revealed serious issues with device quality and unreported injuries. Investors who bought shares between July 30, 2025, and February 24, 2026, are encouraged to join the case before the November 3, 2026 deadline to seek recovery for losses.
Southern Company, operating through Georgia Power, Alabama Power, and Mississippi Power, reported a data breach compromising customer personal information including names, addresses, Social Security numbers, and financial details. This breach raises ...
Intel's stock price has almost tripled in 2026, showing strong recent performance. However, a $10,000 investment in Intel made in 2016 would still be worth less than if it had been invested in the S&P 500 index. This highlights that despite recent ga...
Particula has assigned a AAA-rating to WisdomTree Treasury Money Market Digital Fund (WTGXX), a $1.2 billion tokenized money market fund. The fund invests in short-term U.S. Treasury securities and government money market funds, aiming to preserve ca...
AlphaPepe's cryptocurrency presale has surpassed 12,500 holders and raised nearly $3 million before its first public exchange listing, signaling strong community growth. More than 100 new holders join daily, with a fifth centralized exchange (CEX) pa...
Coinbase has issued a technical paper urging Bitcoin developers to start preparing for future quantum computing threats, which could compromise Bitcoin's current cryptographic security. The company, holding about 5% of all Bitcoin, highlights that tr...
